Evaluation of Bone Turnover Markers in Patients with Acute and Chronic Leukemia.
Indian J Clin Biochem
; 39(3): 401-407, 2024 Jul.
Article
em En
| MEDLINE
| ID: mdl-39005859
ABSTRACT
This study investigated different bone biomarkers (cross-linked carboxy-terminal telopeptide of type 1 collagen (CTX-1), pyridinoline (PYD), osteocalcin (OC), interleukin-6 receptor (IL-6R), calcium (Ca), and magnesium (Mg)) in terms of their metabolism in 4 different leukemia subtypes (ALL, AML, CLL and CML). The design was case control study with 30 controls and 60 cases of leukemia patients. Authors have reported many results regarding decrease as well as increase of specific bone biomarker under investigation with each leukemia subtype when compared to control. In addition, Authors reported correlations between each biomarker level and leukemia subtypes.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Indian J Clin Biochem
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Iraque